Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Berlex commences launch of Campath in U.S.

June 7, 2001

Herceptin reaches market in Japan

June 5, 2001

Topical immune response modifier provides high response rate in phase II trial in sBCC

June 5, 2001

European authorities grant orphan drug designation for pemtumomab

June 5, 2001

Wilex antibody receives orphan drug status for RCC from FDA

June 1, 2001

Oxxon Pharmaccines begins melanoma pharmaccine trials

May 30, 2001

Avicine may be as effective as traditional chemotherapy in pancreatic cancer

May 29, 2001

Neose Technologies and BMS amend cancer vaccine collaboration

May 29, 2001

CancerVax therapeutic vaccine significantly increases survival in late-stage cancers

May 22, 2001

High two-year survival rates obtained in stage III melanoma patients immunized with TriGem

May 21, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...